Rakuten Investment Management, Inc.
Position in REGN — Regeneron Pharmaceuticals, Inc.
CIK 2062680
TOKYO, M0
Position in REGN
as of Jun 30, 2026
· filed Aug 18, 2026
Position Value
$15,326,613
-$1,099,713 QoQ
Shares Held
24,580
+15.6% QoQ
Ownership
0.024%
of shares outstanding
% of Portfolio
0.14%
of 13F equity value
Holder Rank
#239
of 1,322 holders
Holding Since
Dec 2023
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Rakuten Investment Management, Inc. holds $59,330,921 across 7 Biotechnology names. REGN ranks #2 (25.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
61,183 | $30,391,431 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
24,580 | $15,326,613 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
17,961 | $5,406,799 | |
| 4 | INCY |
Incyte Corp
|
27,525 | $3,120,234 | |
| 5 | MRNA |
Moderna, Inc.
|
37,441 | $2,621,993 | |
| 6 | INSM |
INSMED Inc
|
12,109 | $1,291,061 | |
| 7 | TECH |
BIO-TECHNE Corp
|
16,600 | $1,172,790 |
All Filings in REGN
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $15,326,613 | 24,580 | Shares | Sole | 2026-08-18 | |
| 2026-03-31 | $16,426,326 | 21,260 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $14,667,845 | 19,003 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $4,891,554 | 58,906 | Shares | Sole | 2025-10-30 | |
| 2025-03-31 | $8,639,481 | 13,622 | Shares | Sole | 2025-05-15 | |
| 2024-09-30 | $8,956,564 | 8,520 | Shares | Sole | 2025-05-15 | |
| 2024-06-30 | $6,643,560 | 6,321 | Shares | Sole | 2025-05-15 | |
| 2024-03-31 | $3,743,123 | 3,889 | Shares | Sole | 2025-05-15 | |
| 2023-12-31 | $232,746 | 265 | Shares | Sole | 2025-05-15 | |
| No filing history on record for this holder in this stock. | ||||||